Cargando…

Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease

Background: Atrial fibrillation is more common in men, but in the presence of ischemic heart disease, this arrhythmia is more frequent in women. However, like in coronary heart disease, women with atrial fibrillation are suboptimally treated. Methods: To identify particularities of ablation, in wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Irimie, Diana Andrada, Sitar-Tăut, Adela Viviana, Caloian, Bogdan, Frîngu, Florina, Cismaru, Gabriel, Roşu, Radu, Puiu, Mihai, Minciună, Ioan Alexandru, Simu, Gelu, Zdrenghea, Dumitru, Pop, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571300/
https://www.ncbi.nlm.nih.gov/pubmed/36233431
http://dx.doi.org/10.3390/jcm11195568
_version_ 1784810330290913280
author Irimie, Diana Andrada
Sitar-Tăut, Adela Viviana
Caloian, Bogdan
Frîngu, Florina
Cismaru, Gabriel
Roşu, Radu
Puiu, Mihai
Minciună, Ioan Alexandru
Simu, Gelu
Zdrenghea, Dumitru
Pop, Dana
author_facet Irimie, Diana Andrada
Sitar-Tăut, Adela Viviana
Caloian, Bogdan
Frîngu, Florina
Cismaru, Gabriel
Roşu, Radu
Puiu, Mihai
Minciună, Ioan Alexandru
Simu, Gelu
Zdrenghea, Dumitru
Pop, Dana
author_sort Irimie, Diana Andrada
collection PubMed
description Background: Atrial fibrillation is more common in men, but in the presence of ischemic heart disease, this arrhythmia is more frequent in women. However, like in coronary heart disease, women with atrial fibrillation are suboptimally treated. Methods: To identify particularities of ablation, in women with atrial fibrillation and ischemic heart disease. Results: 29 women and 26 men, with documented ischemic heart disease and atrial fibrillation, who underwent catheter ablation, were admitted in the study. No significant differences were registered regarding the heart rate control treatment. Electrical cardioversion was significantly higher in men, while pharmacological cardioversion was predominantly recommended in women. The ablation was performed later in women, after 2.55 ± 1.84 years versus 1.80 ± 1.05 in men (p = 0.05). The time elapsed until the ablation was performed was statistically correlated with atypical symptomatology and with the number of antiarrhythmics used prior to the ablation. There were no significant differences for the relapse of atrial fibrillation at 3 months. Quality of life at 3 months after ablation was increased in both groups. Conclusion: Catheter ablation is performed much later in women, and the causes responsible for this delay would be more atypical symptoms and a greater number of antiarrhythmics tried before the ablation.
format Online
Article
Text
id pubmed-9571300
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95713002022-10-17 Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease Irimie, Diana Andrada Sitar-Tăut, Adela Viviana Caloian, Bogdan Frîngu, Florina Cismaru, Gabriel Roşu, Radu Puiu, Mihai Minciună, Ioan Alexandru Simu, Gelu Zdrenghea, Dumitru Pop, Dana J Clin Med Article Background: Atrial fibrillation is more common in men, but in the presence of ischemic heart disease, this arrhythmia is more frequent in women. However, like in coronary heart disease, women with atrial fibrillation are suboptimally treated. Methods: To identify particularities of ablation, in women with atrial fibrillation and ischemic heart disease. Results: 29 women and 26 men, with documented ischemic heart disease and atrial fibrillation, who underwent catheter ablation, were admitted in the study. No significant differences were registered regarding the heart rate control treatment. Electrical cardioversion was significantly higher in men, while pharmacological cardioversion was predominantly recommended in women. The ablation was performed later in women, after 2.55 ± 1.84 years versus 1.80 ± 1.05 in men (p = 0.05). The time elapsed until the ablation was performed was statistically correlated with atypical symptomatology and with the number of antiarrhythmics used prior to the ablation. There were no significant differences for the relapse of atrial fibrillation at 3 months. Quality of life at 3 months after ablation was increased in both groups. Conclusion: Catheter ablation is performed much later in women, and the causes responsible for this delay would be more atypical symptoms and a greater number of antiarrhythmics tried before the ablation. MDPI 2022-09-22 /pmc/articles/PMC9571300/ /pubmed/36233431 http://dx.doi.org/10.3390/jcm11195568 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Irimie, Diana Andrada
Sitar-Tăut, Adela Viviana
Caloian, Bogdan
Frîngu, Florina
Cismaru, Gabriel
Roşu, Radu
Puiu, Mihai
Minciună, Ioan Alexandru
Simu, Gelu
Zdrenghea, Dumitru
Pop, Dana
Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease
title Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease
title_full Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease
title_fullStr Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease
title_full_unstemmed Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease
title_short Particularities of Catheter Ablation in Women with Atrial Fibrillation and Associated Ischemic Heart Disease
title_sort particularities of catheter ablation in women with atrial fibrillation and associated ischemic heart disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571300/
https://www.ncbi.nlm.nih.gov/pubmed/36233431
http://dx.doi.org/10.3390/jcm11195568
work_keys_str_mv AT irimiedianaandrada particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT sitartautadelaviviana particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT caloianbogdan particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT fringuflorina particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT cismarugabriel particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT rosuradu particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT puiumihai particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT minciunaioanalexandru particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT simugelu particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT zdrengheadumitru particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease
AT popdana particularitiesofcatheterablationinwomenwithatrialfibrillationandassociatedischemicheartdisease